Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Demant A/S
  6. Summary
    DEMANT   DK0060738599

DEMANT A/S

(DEMANT)
  Report
Real-time Estimate Cboe Europe  -  11:00 2022-09-30 am EDT
188.95 DKK   +4.02%
08/16Global markets live: Walmart, Home Depot, Darktrace, Twitter, Merck...
MS
08/16Demant A/S Revises Earnings Guidance for the Full Year 2022
CI
08/16Transcript : Demant A/S, H1 2022 Earnings Call, Aug 16, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
09/26/2022 09/27/2022 09/28/2022 09/29/2022 09/30/2022 Date
196.5(c) 193.35(c) 189.5(c) 181.65(c) 188.95 Last
176 161 252 351 246 436 349 511 306 453 Volume
+1.60% -1.60% -1.99% -4.14% +4.02% Change
More quotes
Estimated financial data (e)
Sales 2022 19 958 M 2 623 M 2 623 M
Net income 2022 2 453 M 322 M 322 M
Net Debt 2022 11 112 M 1 460 M 1 460 M
P/E ratio 2022 16,7x
Yield 2022 -
Sales 2023 21 590 M 2 837 M 2 837 M
Net income 2023 2 887 M 379 M 379 M
Net Debt 2023 11 472 M 1 508 M 1 508 M
P/E ratio 2023 13,8x
Yield 2023 -
Capitalization 40 032 M 5 261 M 5 261 M
EV / Sales 2022 2,56x
EV / Sales 2023 2,39x
Nbr of Employees 18 548
Free-Float 32,0%
More Financials
Company
Demant A/S is the world's 2nd leading producer of audio products. Net sales break down by family of products as follows: - tailor-made hearing aids (80.9%): hearing aid and audiphones manufactured under the Oticon, Bernafon, Philips and Sonic brands; - diagnostic products (9.9%): audiometers sold under the Maico and Interacoustics brands; - business communication solutions (6.4%); - hearing implants (2.8%):... 
More about the company
Ratings of Demant A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about DEMANT A/S
08/16Global markets live: Walmart, Home Depot, Darktrace, Twitter, Merck...
MS
08/16Demant A/S Revises Earnings Guidance for the Full Year 2022
CI
08/16Transcript : Demant A/S, H1 2022 Earnings Call, Aug 16, 2022
CI
08/16Demant Cuts FY22 Outlook On Negative Impacts Of Consumer Uncertainty
MT
08/16Demant A/s : Interim Report 2022
AQ
08/16Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.
CI
08/16Demant A/S Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/16DEMANT A/S : Half-year report
CO
08/12Demant A/s : Investor news - comparative figures for 2021
AQ
07/05Demant Secures $105 Million Loan From Nordic Investment Bank
MT
06/14Demant Assumes Full Ownership of Chinese Hearing Aid Clinic Network
MT
06/14Demant A/s : Demant completes full acquisition of ShengWang
AQ
06/14Demant A/S acquired remaining 80% interest in ShengWang for CNY.
CI
05/03Global markets live: BP, Pfizer, Expedia, Citigroup, Amazon...
MS
05/03Transcript : Demant A/S, 4 Months 2022 Interim Management Statement Call, May..
CI
More news
News in other languages on DEMANT A/S
09/13Reunión a las 14.30 horas
09/13Avis d'analystes du jour : Saint-Gobain, Eurofins, JCDecaux, Eu..
09/13Rendez-vous à 14h30
08/25Bolsa de Madrid: D-1 antes de Jackson Hole
08/25J-1 avant Jackson Hole
More news
Analyst Recommendations on DEMANT A/S
More recommendations
ETFs positioned on DEMANT A/SETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
HAN-GINS Indxx Healthcare Megatrend Equal W...0.85%0.44%-NC
IShares STOXX Europe Small 200 (DE) - EUR0.64%-6.26%Europe
Global X Longevity Thematic ETF - USD0.63%-0.68%World
Xtrackers MSCI Nordic 1D - EUR0.31%-2.79%Nordic
Inspire Global Hope ETF - USD0.26%-3.77%World
More ETFs positioned on DEMANT A/S
Chart DEMANT A/S
Duration : Period :
Demant A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DEMANT A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 181,65 DKK
Average target price 270,36 DKK
Spread / Average Target 48,8%
EPS Revisions
Managers and Directors
S°ren Nielsen President & Chief Executive Officer
RenÚ Schneider Chief Financial Officer
Niels Bj°rn Christiansen Chairman
Anja Madsen Independent Director
Kristian Villumsen Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DEMANT A/S-43.45%5 261
STRAUMANN HOLDING AG-53.62%14 614
SONOVA HOLDING AG-39.49%13 512
COCHLEAR LIMITED-6.04%8 659
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.-6.77%2 826
ANGELALIGN TECHNOLOGY INC.-70.75%1 611